🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 10/03/1994 | 15,51 | 15,51 | 15,15 | 15,21 | -1,54% | 2,31% | 5.227.634 |
| 09/03/1994 | 15,21 | 15,45 | 14,97 | 15,45 | +1,97% | 3,14% | 5.600.093 |
| 08/03/1994 | 15,33 | 15,39 | 15,03 | 15,15 | -0,78% | 2,33% | 3.981.771 |
| 07/03/1994 | 15,03 | 15,39 | 15,03 | 15,27 | +3,23% | 2,38% | 7.924.976 |
| 04/03/1994 | 14,97 | 15,03 | 14,67 | 14,79 | -1,59% | 2,39% | 6.310.008 |
| 03/03/1994 | 15,27 | 15,39 | 14,79 | 15,03 | -1,56% | 3,91% | 9.495.299 |
| 02/03/1994 | 14,91 | 15,27 | 14,79 | 15,27 | +0,00% | 3,20% | 6.167.270 |
| 01/03/1994 | 15,39 | 15,45 | 15,09 | 15,27 | -1,16% | 2,33% | 5.968.360 |
| 28/02/1994 | 15,57 | 15,68 | 15,45 | 15,45 | +0,39% | 1,53% | 5.747.861 |
| 25/02/1994 | 15,33 | 15,51 | 15,21 | 15,39 | +1,18% | 1,95% | 5.043.186 |
| 24/02/1994 | 15,51 | 15,51 | 15,15 | 15,21 | -1,92% | 2,31% | 7.843.651 |
| 23/02/1994 | 15,63 | 15,86 | 15,51 | 15,51 | -0,38% | 2,29% | 6.711.182 |
| 22/02/1994 | 15,74 | 15,80 | 15,45 | 15,57 | -0,76% | 2,27% | 6.480.413 |
| 18/02/1994 | 15,80 | 15,86 | 15,63 | 15,68 | -0,75% | 1,51% | 6.727.950 |
| 17/02/1994 | 16,04 | 16,04 | 15,68 | 15,80 | +0,00% | 2,23% | 6.549.371 |
| 16/02/1994 | 16,04 | 16,10 | 15,74 | 15,80 | -1,85% | 2,23% | 7.395.317 |
| 15/02/1994 | 16,10 | 16,22 | 15,98 | 16,10 | +0,00% | 1,48% | 7.153.648 |
| 14/02/1994 | 16,64 | 16,64 | 16,10 | 16,10 | -3,23% | 3,23% | 7.449.813 |
| 11/02/1994 | 16,52 | 16,88 | 16,46 | 16,64 | +0,00% | 2,53% | 4.485.650 |
| 10/02/1994 | 16,64 | 16,94 | 16,58 | 16,64 | +0,00% | 2,15% | 7.018.875 |
| 09/02/1994 | 16,52 | 16,64 | 16,40 | 16,64 | +1,09% | 1,44% | 3.995.605 |
| 08/02/1994 | 16,76 | 16,76 | 16,40 | 16,46 | -1,78% | 2,14% | 6.076.304 |
| 07/02/1994 | 16,64 | 16,88 | 16,64 | 16,76 | +0,00% | 1,43% | 7.206.886 |
| 04/02/1994 | 17,47 | 17,47 | 16,70 | 16,76 | -3,77% | 4,44% | 5.906.738 |
| 03/02/1994 | 17,29 | 17,53 | 16,88 | 17,41 | +0,34% | 3,79% | 6.121.158 |
| 02/02/1994 | 17,29 | 17,41 | 17,24 | 17,35 | +0,35% | 1,03% | 3.964.794 |
| 01/02/1994 | 17,35 | 17,41 | 17,24 | 17,29 | -0,69% | 1,03% | 4.555.027 |
| 31/01/1994 | 17,29 | 17,41 | 17,18 | 17,41 | +1,39% | 1,38% | 5.644.947 |
| 28/01/1994 | 17,18 | 17,41 | 17,00 | 17,18 | +0,70% | 2,43% | 5.556.077 |
| 27/01/1994 | 17,12 | 17,18 | 16,94 | 17,06 | -0,35% | 1,39% | 3.822.685 |